NCT03451825 2024-06-24Phase I/II Study of Avelumab in Pediatric Cancer ParticipantsEMD SeronoPhase 1 Terminated21 enrolled 21 charts
NCT02968940 2022-06-29Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant GlioblastomaNYU Langone HealthPhase 2 Completed6 enrolled 10 charts